The research provides insights into Major Depression epidemiology, Major Depression diagnosed patients, and Major Depression treatment rate for US, Japan, and EU5 countries. The research measures key indicators including prevalence of Major Depression derived from epidemiological analysis, patients diagnosed with Major Depression, and patients treated with a drug therapy.
The research study helps executives estimate Major Depression market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The research provides estimates and forecasts of Major Depression prevalence, Major Depression diagnosis rate, and Major Depression treatment rate for the period 2017 - 2026. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan.